Literature DB >> 19289518

The octadecyloxyethyl ester of (S)-9-[3-hydroxy-2-(phosphonomethoxy) propyl]adenine is a potent and selective inhibitor of hepatitis C virus replication in genotype 1A, 1B, and 2A replicons.

David L Wyles1, Kelly A Kaihara, Brent E Korba, Robert T Schooley, James R Beadle, Karl Y Hostetler.   

Abstract

The octadecyloxyethyl (ODE) and hexadecyloxypropyl (HDP) esters of (S)-9-[3-hydroxy-2-(phosphonomethoxy)propyl]adenine (HPMPA) are potent inhibitors of orthopoxvirus, herpesvirus, human immunodeficiency virus type 1, and hepatitis B virus replication in vitro. HDP and ODE esters of (S)-HPMPA and (R)-HPMPA were evaluated for their activity in hepatitis C virus (HCV) replicon assays using luciferase (1B and 2A replicons) or RNA (1B) quantification. The ODE ester of (S)-HPMPA [ODE-(S)-HPMPA] was the most active compound, with 50% effective concentrations (EC(50)s) in the 0.69 to 1.31 microM range. HDP and ODE esters of (R)-HPMPA were severalfold less active, while (S)-HPMPA and (R)-HPMPA were inactive. In genotype 1A and 1B replicons analyzed by HCV RNA analysis, ODE-(S)-HPMPA was the most active compound, with EC(50)s of 1.8 and 2.1 microM, respectively.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19289518      PMCID: PMC2687240          DOI: 10.1128/AAC.01546-08

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  26 in total

1.  Enhanced antiproliferative effects of alkoxyalkyl esters of cidofovir in human cervical cancer cells in vitro.

Authors:  Karl Y Hostetler; Steffney Rought; Kathy A Aldern; Julissa Trahan; James R Beadle; Jacques Corbeil
Journal:  Mol Cancer Ther       Date:  2006-01       Impact factor: 6.261

2.  Synergy of small molecular inhibitors of hepatitis C virus replication directed at multiple viral targets.

Authors:  David L Wyles; Kelly A Kaihara; Florin Vaida; Robert T Schooley
Journal:  J Virol       Date:  2006-12-20       Impact factor: 5.103

3.  Synthesis and antiviral evaluation of alkoxyalkyl derivatives of 9-(S)-(3-hydroxy-2-phosphonomethoxypropyl)adenine against cytomegalovirus and orthopoxviruses.

Authors:  James R Beadle; William B Wan; Stephanie L Ciesla; Kathy A Keith; Caroll Hartline; Earl R Kern; Karl Y Hostetler
Journal:  J Med Chem       Date:  2006-03-23       Impact factor: 7.446

4.  2'-deoxy-4'-azido nucleoside analogs are highly potent inhibitors of hepatitis C virus replication despite the lack of 2'-alpha-hydroxyl groups.

Authors:  Klaus Klumpp; Genadiy Kalayanov; Han Ma; Sophie Le Pogam; Vincent Leveque; Wen-Rong Jiang; Nicole Inocencio; Anniek De Witte; Sonal Rajyaguru; Ezra Tai; Sushmita Chanda; Michael R Irwin; Christian Sund; Anna Winqist; Tatiana Maltseva; Staffan Eriksson; Elena Usova; Mark Smith; Andre Alker; Isabel Najera; Nick Cammack; Joseph A Martin; Nils Gunnar Johansson; David B Smith
Journal:  J Biol Chem       Date:  2007-11-14       Impact factor: 5.157

5.  Nitazoxanide, tizoxanide and other thiazolides are potent inhibitors of hepatitis B virus and hepatitis C virus replication.

Authors:  Brent E Korba; Abigail B Montero; Kristine Farrar; Karen Gaye; Sampa Mukerjee; Marc S Ayers; Jean-François Rossignol
Journal:  Antiviral Res       Date:  2007-09-04       Impact factor: 5.970

6.  Evaluation of hexadecyloxypropyl-9-R-[2-(Phosphonomethoxy)propyl]- adenine, CMX157, as a potential treatment for human immunodeficiency virus type 1 and hepatitis B virus infections.

Authors:  George R Painter; Merrick R Almond; Lawrence C Trost; Bernhard M Lampert; Johan Neyts; Erik De Clercq; Brent E Korba; Kathy A Aldern; James R Beadle; Karl Y Hostetler
Journal:  Antimicrob Agents Chemother       Date:  2007-07-23       Impact factor: 5.191

7.  Cidofovir and (S)-9-[3-hydroxy-(2-phosphonomethoxy)propyl]adenine are highly effective inhibitors of vaccinia virus DNA polymerase when incorporated into the template strand.

Authors:  Wendy C Magee; Kathy A Aldern; Karl Y Hostetler; David H Evans
Journal:  Antimicrob Agents Chemother       Date:  2007-12-03       Impact factor: 5.191

8.  Effect of oral treatment with hexadecyloxypropyl-[(S)-9-(3-hydroxy-2- phosphonylmethoxypropyl)adenine] [(S)-HPMPA] or octadecyloxyethyl-(S)-HPMPA on cowpox or vaccinia virus infections in mice.

Authors:  Debra C Quenelle; Deborah J Collins; Bridgett P Herrod; Kathy A Keith; Julissa Trahan; James R Beadle; Karl Y Hostetler; Earl R Kern
Journal:  Antimicrob Agents Chemother       Date:  2007-09-10       Impact factor: 5.191

9.  Identification and biological characterization of heterocyclic inhibitors of the hepatitis C virus RNA-dependent RNA polymerase.

Authors:  Dashyant Dhanak; Kevin J Duffy; Victor K Johnston; Juili Lin-Goerke; Michael Darcy; Antony N Shaw; Baohua Gu; Carol Silverman; Adam T Gates; Michael R Nonnemacher; David L Earnshaw; David J Casper; Arun Kaura; Audrey Baker; Cathy Greenwood; Lester L Gutshall; Derrick Maley; Alfred DelVecchio; Ricardo Macarron; Glenn A Hofmann; Zaid Alnoah; Hung-Yuan Cheng; George Chan; Sanjay Khandekar; Richard M Keenan; Robert T Sarisky
Journal:  J Biol Chem       Date:  2002-08-06       Impact factor: 5.157

10.  The hepatitis C virus replicon presents a higher barrier to resistance to nucleoside analogs than to nonnucleoside polymerase or protease inhibitors.

Authors:  Matthew F McCown; Sonal Rajyaguru; Sophie Le Pogam; Samir Ali; Wen-Rong Jiang; Hyunsoon Kang; Julian Symons; Nick Cammack; Isabel Najera
Journal:  Antimicrob Agents Chemother       Date:  2008-02-19       Impact factor: 5.191

View more
  23 in total

1.  Evaluation of ITX 5061, a scavenger receptor B1 antagonist: resistance selection and activity in combination with other hepatitis C virus antivirals.

Authors:  Haihong Zhu; Flossie Wong-Staal; Haekyung Lee; Andrew Syder; Jeffrey McKelvy; Robert T Schooley; David L Wyles
Journal:  J Infect Dis       Date:  2012-02-15       Impact factor: 5.226

Review 2.  Advances in nucleoside monophosphate prodrugs as anti-HCV agents.

Authors:  Drew R Bobeck; Raymond F Schinazi; Steven J Coats
Journal:  Antivir Ther       Date:  2010

3.  Synthesis and antiviral evaluation of 9-(S)-[3-alkoxy-2-(phosphonomethoxy)propyl]nucleoside alkoxyalkyl esters: inhibitors of hepatitis C virus and HIV-1 replication.

Authors:  Nadejda Valiaeva; David L Wyles; Robert T Schooley; Julia B Hwu; James R Beadle; Mark N Prichard; Karl Y Hostetler
Journal:  Bioorg Med Chem       Date:  2011-06-13       Impact factor: 3.641

4.  Foot-and-mouth disease virus genome replication is unaffected by inhibition of type III phosphatidylinositol-4-kinases.

Authors:  Eleni-Anna Loundras; Morgan R Herod; Mark Harris; Nicola J Stonehouse
Journal:  J Gen Virol       Date:  2016-06-20       Impact factor: 3.891

5.  Early events in the generation of autophagosomes are required for the formation of membrane structures involved in hepatitis C virus genome replication.

Authors:  Bjorn-Patrick Mohl; Christopher Bartlett; Jamel Mankouri; Mark Harris
Journal:  J Gen Virol       Date:  2016-01-04       Impact factor: 3.891

6.  Vitamin D Metabolites Inhibit Hepatitis C Virus and Modulate Cellular Gene Expression.

Authors:  Julio A Gutierrez; Krysten A Jones; Roxana Flores; Akul Singhania; Christopher H Woelk; Robert T Schooley; David L Wyles
Journal:  J Virol Antivir Res       Date:  2014-10-06

7.  Antischistosomal activity of hexadecyloxypropyl cyclic 9-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]adenine and other alkoxyalkyl esters of acyclic nucleoside phosphonates assessed by schistosome worm killing in vitro.

Authors:  Sanaa S Botros; Samia William; James R Beadle; Nadejda Valiaeva; Karl Y Hostetler
Journal:  Antimicrob Agents Chemother       Date:  2009-08-24       Impact factor: 5.191

8.  Alkoxyalkyl esters of 9-(s)-(3-hydroxy-2-phosphonomethoxypropyl) adenine are potent and selective inhibitors of hepatitis B virus (HBV) replication in vitro and in HBV transgenic mice in vivo.

Authors:  John D Morrey; Brent E Korba; James R Beadle; David L Wyles; Karl Y Hostetler
Journal:  Antimicrob Agents Chemother       Date:  2009-04-27       Impact factor: 5.191

9.  Hepatitis C virus-induced autophagy is independent of the unfolded protein response.

Authors:  Bjorn-Patrick Mohl; Philip R Tedbury; Stephen Griffin; Mark Harris
Journal:  J Virol       Date:  2012-07-25       Impact factor: 5.103

10.  Inhibition of hepatitis C virus using siRNA targeted to the virus and Hsp90.

Authors:  Ana Claudia Silva Braga; Bruno Moreira Carneiro; Mariana Nogueira Batista; Mônica Mayumi Akinaga; Paula Rahal
Journal:  Cell Stress Chaperones       Date:  2016-11-17       Impact factor: 3.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.